SynCardia Granted Second Patent Covering Fully Implantable Artificial Heart

SynCardia Systems, LLC., a Picard Medical Inc. company, is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued a second patent (US patent no. 12,121,711 B2) that will expand the coverage of SynCardia’s fully implantable artificial heart technology (SynCardia Emperor). The USPTO allowed the first patent (US patent no. 11,918,797) relating to its groundbreaking “Next Generation Total Artificial Heart” designs in March of this year.

Study: Making an artificial heart fit for a human — with focused rotary jet spinning, not 3D

In a new study published in Science, a team of researchers from Harvard, University of Pittsburgh, University of California, Irvine and University of Zurich have come together to utilize a new, more advanced method to fabricate artificial tissues and organs. The researchers proposed the process of focused rotary jet spinning. This team included Qihan Liu, an assistant professor in the University of Pittsburgh Swanson School of Engineering.